Hims & Hers strong performance involves much more than just GLP-1 drugs.Hims & Hers Health (HIMS 0.85%) reported another blowout quarter recently, but the stock didn't get the type of pop that might typically be seen with such an earnings beat. The stock has been very volatile this year, with its shares trading up and down on any news related to GLP-1 weight loss drugs. So far, the news has generally been good and the stock has still climbed by more than 225% over the past year.Let's take a closer look at t ...